Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Here's what that looks like: The Retatrutide Escalation Protocol (Phase 2 Trial Structure) Weeks 1-4: 2 mg subcutaneous injection, once weekly Weeks 5-8: 4 mg once weekly Weeks 9-12: 8 mg once weekly Weeks 13-16: 12 mg once weekly (highest dose arm) Week 17+: Maintenance at the highest tolerated dose In the Phase 2 trial published in The New England Journal of Medicine , participants in the highest dose group (12 mg) lost a mean of 24.2% of body weight at 48 weeks
The medication was still helping, just not as visibly, and removing the behavioral scaffolding around it eliminates the remaining benefit
.png)
Read the guide GLP-1 Medications and Insurance: What's Actually Covered in 2026 The insurance landscape for GLP-1 medications changed significantly in 2025 and 2026
5-amino-1mq appears to preserve muscle during fat loss, with studies showing treated subjects losing 10 to 15% less muscle than controls
